HCA250516P255000
- 5.70
- 0.000.00%
HCA Healthcare Newsroom
HCA Healthcare Approves New Compensation Program
A Quick Look at Today's Ratings for HCA Healthcare(HCA.US), With a Forecast Between $355 to $390
HCA Healthcare Price Target Cut to $376.00/Share From $384.00 by RBC Capital
HCA Healthcare Is Maintained at Outperform by RBC Capital
HCA Healthcare Analyst Ratings
Analysts Conflicted on These Healthcare Names: HCA Healthcare (HCA), Edwards Lifesciences (EW) and Gilead Sciences (GILD)
HCA Healthcare Price Target Lowered to $361 From $377 at TD Cowen
KeyBanc Maintains HCA Healthcare(HCA.US) With Buy Rating, Maintains Target Price $370
Barclays Maintains HCA Healthcare(HCA.US) With Buy Rating, Maintains Target Price $366
RBC Lowers Price Target on HCA Healthcare to $376 From $384, Keeps Outperform Rating
Express News | HCA Healthcare Inc : Leerink Partners Cuts Target Price to $390.00 From $404.00
KeyBanc Keeps Their Buy Rating on HCA Healthcare (HCA)
Barclays Remains a Buy on HCA Healthcare (HCA)
HCA Healthcare Reports Strong Q1 Earnings Growth
HCA Healthcare To Go Ex-Dividend On June 16th, 2025 With 0.72 USD Dividend Per Share
HCA Healthcare Inc. Stock Falls 4.0%, Underperforms Market
Express News | HCA Healthcare Shares Are Trading Lower Following Q1 Earnings
Earnings Call Summary | HCA Healthcare(HCA.US) Q1 2025 Earnings Conference
HCA Healthcare Projects $5.1B Capital Spending in 2025 With Focus on Network Expansion
Research Alert: CFRA Maintains Buy Opinion On Shares Of Hca Healthcare, Inc.